The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Protein Processing, Post-Translational

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Protein Processing, Post-Translational


Psychiatry related information on Protein Processing, Post-Translational


High impact information on Protein Processing, Post-Translational


Chemical compound and disease context of Protein Processing, Post-Translational


Biological context of Protein Processing, Post-Translational


Anatomical context of Protein Processing, Post-Translational


Associations of Protein Processing, Post-Translational with chemical compounds


Gene context of Protein Processing, Post-Translational


Analytical, diagnostic and therapeutic context of Protein Processing, Post-Translational

  • Microinjection of cells with an antibody specific to the C-terminal negative regulatory domain can activate the function of p53 as a specific transcription factor in the absence of irradiation damage, suggesting that posttranslational modification of a negative regulatory domain in vivo is a rate-limiting step for p53 activation [37].
  • Western blots of two-dimensional gels of amoebal and flagellate proteins reveal that this antibody recognizes the alpha 3 tubulin isotype, which was previously shown to be formed by posttranslational modification (Green, L. L., and W. F. Dove, 1984, Mol. Cell. Biol., 4:1706-1711) [38].
  • Here we have established the pathway of posttranslational modification of Kex2 protein using immunoprecipitation of the biosynthetically pulse-labeled protein from a variety of wild-type and mutant yeast strains as the principal methodology [39].
  • Metabolic labeling with GalNAz followed by Staudinger ligation provides a means for proteomic analysis of this posttranslational modification and for identifying O-linked glycoprotein fingerprints associated with disease [40].
  • Signal transducer and activator of transcription 1 (STAT1) is a critical mediator of interferon-gamma (IFN-gamma)-induced transcription that is regulated through posttranslational modifications and through transacting proteins such as protein inhibitor of activated STAT1 (PIAS1) [41].


  1. How to flip the (redox) switch. Georgiou, G. Cell (2002) [Pubmed]
  2. Fatty acid binding to vesicular stomatitis virus glycoprotein: a new type of post-translational modification of the viral glycoprotein. Schmidt, M.F., Schlesinger, M.J. Cell (1979) [Pubmed]
  3. A membrane glycoprotein that accumulates intracellularly: cellular processing of the large glycoprotein of LaCrosse virus. Madoff, D.H., Lenard, J. Cell (1982) [Pubmed]
  4. Strain-specific prion-protein conformation determined by metal ions. Wadsworth, J.D., Hill, A.F., Joiner, S., Jackson, G.S., Clarke, A.R., Collinge, J. Nat. Cell Biol. (1999) [Pubmed]
  5. Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells. Capony, F., Morisset, M., Barrett, A.J., Capony, J.P., Broquet, P., Vignon, F., Chambon, M., Louisot, P., Rochefort, H. J. Cell Biol. (1987) [Pubmed]
  6. Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease. Wang, J.Z., Grundke-Iqbal, I., Iqbal, K. Nat. Med. (1996) [Pubmed]
  7. Protein modification by SUMO. Johnson, E.S. Annu. Rev. Biochem. (2004) [Pubmed]
  8. Physiology of nitric oxide in skeletal muscle. Stamler, J.S., Meissner, G. Physiol. Rev. (2001) [Pubmed]
  9. Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation. Yu, W., Ginjala, V., Pant, V., Chernukhin, I., Whitehead, J., Docquier, F., Farrar, D., Tavoosidana, G., Mukhopadhyay, R., Kanduri, C., Oshimura, M., Feinberg, A.P., Lobanenkov, V., Klenova, E., Ohlsson, R. Nat. Genet. (2004) [Pubmed]
  10. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Topaz, O., Shurman, D.L., Bergman, R., Indelman, M., Ratajczak, P., Mizrachi, M., Khamaysi, Z., Behar, D., Petronius, D., Friedman, V., Zelikovic, I., Raimer, S., Metzker, A., Richard, G., Sprecher, E. Nat. Genet. (2004) [Pubmed]
  11. Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Pawson, T. Cell (2004) [Pubmed]
  12. Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376. Valmori, D., Pittet, M.J., Vonarbourg, C., Rimoldi, D., Liénard, D., Speiser, D., Dunbar, R., Cerundolo, V., Cerottini, J.C., Romero, P. Cancer Res. (1999) [Pubmed]
  13. Structure, expression, and evolution of a gene encoding the precursor of nisin, a small protein antibiotic. Buchman, G.W., Banerjee, S., Hansen, J.N. J. Biol. Chem. (1988) [Pubmed]
  14. alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Cairns, N.J., Zhukareva, V., Uryu, K., Zhang, B., Bigio, E., Mackenzie, I.R., Gearing, M., Duyckaerts, C., Yokoo, H., Nakazato, Y., Jaros, E., Perry, R.H., Lee, V.M., Trojanowski, J.Q. Am. J. Pathol. (2004) [Pubmed]
  15. Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147. Ryan, M.P., Jack, R.W., Josten, M., Sahl, H.G., Jung, G., Ross, R.P., Hill, C. J. Biol. Chem. (1999) [Pubmed]
  16. Cardiac mitochondrial NADP+-isocitrate dehydrogenase is inactivated through 4-hydroxynonenal adduct formation: an event that precedes hypertrophy development. Benderdour, M., Charron, G., DeBlois, D., Comte, B., Des Rosiers, C. J. Biol. Chem. (2003) [Pubmed]
  17. Small nuclear ribonucleoprotein particle assembly in vivo: demonstration of a 6S RNA-free core precursor and posttranslational modification. Fisher, D.E., Conner, G.E., Reeves, W.H., Wisniewolski, R., Blobel, G. Cell (1985) [Pubmed]
  18. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Vasan, S., Zhang, X., Zhang, X., Kapurniotu, A., Bernhagen, J., Teichberg, S., Basgen, J., Wagle, D., Shih, D., Terlecky, I., Bucala, R., Cerami, A., Egan, J., Ulrich, P. Nature (1996) [Pubmed]
  19. Deacetylation of p53 modulates its effect on cell growth and apoptosis. Luo, J., Su, F., Chen, D., Shiloh, A., Gu, W. Nature (2000) [Pubmed]
  20. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Zacchi, P., Gostissa, M., Uchida, T., Salvagno, C., Avolio, F., Volinia, S., Ronai, Z., Blandino, G., Schneider, C., Del Sal, G. Nature (2002) [Pubmed]
  21. Inducible expression and phosphorylation of coactivator BOB.1/OBF.1 in T cells. Zwilling, S., Dieckmann, A., Pfisterer, P., Angel, P., Wirth, T. Science (1997) [Pubmed]
  22. Posttranslational formation of hypusine in a single major protein occurs generally in growing cells and is associated with activation of lymphocyte growth. Cooper, H.L., Park, M.H., Folk, J.E. Cell (1982) [Pubmed]
  23. CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice. Cardell, S., Tangri, S., Chan, S., Kronenberg, M., Benoist, C., Mathis, D. J. Exp. Med. (1995) [Pubmed]
  24. Structural protein 4.1 in the nucleus of human cells: dynamic rearrangements during cell division. Krauss, S.W., Larabell, C.A., Lockett, S., Gascard, P., Penman, S., Mohandas, N., Chasis, J.A. J. Cell Biol. (1997) [Pubmed]
  25. Posttranslational modification of elongation factor 2 in diphtheria-toxin-resistant mutants of CHO-K1 cells. Moehring, J.M., Moehring, T.J., Danley, D.E. Proc. Natl. Acad. Sci. U.S.A. (1980) [Pubmed]
  26. Core 2 branching beta1,6-N-acetylglucosaminyltransferase and high endothelial cell N-acetylglucosamine-6-sulfotransferase exert differential control over B- and T-lymphocyte homing to peripheral lymph nodes. Gauguet, J.M., Rosen, S.D., Marth, J.D., von Andrian, U.H. Blood (2004) [Pubmed]
  27. Distinct populations of microtubules: tyrosinated and nontyrosinated alpha tubulin are distributed differently in vivo. Gundersen, G.G., Kalnoski, M.H., Bulinski, J.C. Cell (1984) [Pubmed]
  28. Glycosylation site binding protein, a component of oligosaccharyl transferase, is highly similar to three other 57 kd luminal proteins of the ER. Geetha-Habib, M., Noiva, R., Kaplan, H.A., Lennarz, W.J. Cell (1988) [Pubmed]
  29. Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival. Sotiriou, S., Gispert, S., Cheng, J., Wang, Y., Chen, A., Hoogstraten-Miller, S., Miller, G.F., Kwon, O., Levine, M., Guttentag, S.H., Nussbaum, R.L. Nat. Med. (2002) [Pubmed]
  30. Steroid receptor family: structure and functions. Carson-Jurica, M.A., Schrader, W.T., O'Malley, B.W. Endocr. Rev. (1990) [Pubmed]
  31. Posttranslational glutamylation of alpha-tubulin. Eddé, B., Rossier, J., Le Caer, J.P., Desbruyères, E., Gros, F., Denoulet, P. Science (1990) [Pubmed]
  32. The molecular genetics of components of complement. Campbell, R.D., Carroll, M.C., Porter, R.R. Adv. Immunol. (1986) [Pubmed]
  33. Regulated phosphorylation and dephosphorylation of GAL4, a transcriptional activator. Mylin, L.M., Bhat, J.P., Hopper, J.E. Genes Dev. (1989) [Pubmed]
  34. Methylation of SPT5 regulates its interaction with RNA polymerase II and transcriptional elongation properties. Kwak, Y.T., Guo, J., Prajapati, S., Park, K.J., Surabhi, R.M., Miller, B., Gehrig, P., Gaynor, R.B. Mol. Cell (2003) [Pubmed]
  35. Molecular basis of CD36 deficiency. Evidence that a 478C-->T substitution (proline90-->serine) in CD36 cDNA accounts for CD36 deficiency. Kashiwagi, H., Tomiyama, Y., Honda, S., Kosugi, S., Shiraga, M., Nagao, N., Sekiguchi, S., Kanayama, Y., Kurata, Y., Matsuzawa, Y. J. Clin. Invest. (1995) [Pubmed]
  36. Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2. Singh, U.S., Kunar, M.T., Kao, Y.L., Baker, K.M. EMBO J. (2001) [Pubmed]
  37. Small peptides activate the latent sequence-specific DNA binding function of p53. Hupp, T.R., Sparks, A., Lane, D.P. Cell (1995) [Pubmed]
  38. Distribution of acetylated alpha-tubulin in Physarum polycephalum. Diggins, M.A., Dove, W.F. J. Cell Biol. (1987) [Pubmed]
  39. Posttranslational processing of the prohormone-cleaving Kex2 protease in the Saccharomyces cerevisiae secretory pathway. Wilcox, C.A., Fuller, R.S. J. Cell Biol. (1991) [Pubmed]
  40. Probing mucin-type O-linked glycosylation in living animals. Dube, D.H., Prescher, J.A., Quang, C.N., Bertozzi, C.R. Proc. Natl. Acad. Sci. U.S.A. (2006) [Pubmed]
  41. PIAS proteins promote SUMO-1 conjugation to STAT1. Ungureanu, D., Vanhatupa, S., Kotaja, N., Yang, J., Aittomaki, S., Jänne, O.A., Palvimo, J.J., Silvennoinen, O. Blood (2003) [Pubmed]
WikiGenes - Universities